Cargando…
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study
INTRODUCTION: Genetically characterized patient-derived tumor xenografts (PDX) are a valuable resource to understand the biological complexity of cancer and to investigate new therapeutic approaches. Previous studies, however, lack information about metabolic features of PDXs, which may limit testin...
Autores principales: | Ferrarini, Federica, Zulato, Elisabetta, Moro, Massimo, Del Bianco, Paola, Borzi, Cristina, Esposito, Giovanni, Zanin, Tiziana, Sozzi, Gabriella, Indraccolo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011479/ https://www.ncbi.nlm.nih.gov/pubmed/36925926 http://dx.doi.org/10.3389/fonc.2023.1070505 |
Ejemplares similares
-
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
por: Piga, Ilaria, et al.
Publicado: (2020) -
Establishment of 6 pediatric rhabdomyosarcoma patient’s derived
xenograft models closely recapitulating patients’ tumor
characteristics
por: Gasparini, Patrizia, et al.
Publicado: (2022) -
Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients
por: Zulato, Elisabetta, et al.
Publicado: (2021) -
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
por: Moro, Massimo, et al.
Publicado: (2017) -
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
por: Ciccarese, Francesco, et al.
Publicado: (2019)